Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Will Refer Potentially Anti-Competitive Citizen Petitions To FTC

Executive Summary

Questionable citizen petitions will be referred to the Federal Trade Commission, FDA says in a report made to House and Senate appropriations committees

You may also be interested in...



Medicare Rx Price Negotiation Gets Finance Cmte. Ally With Sen. Stabenow

Supporters of government price negotiations for Medicare Part D prescription drugs will have another Senate Finance Committee ally in the next Congress, with the appointment of Sen. Debbie Stabenow (D-Mich.)

Medicare Rx Price Negotiation Gets Finance Cmte. Ally With Sen. Stabenow

Supporters of government price negotiations for Medicare Part D prescription drugs will have another Senate Finance Committee ally in the next Congress, with the appointment of Sen. Debbie Stabenow (D-Mich.)

Citizen Petitions May Be Enforcement Target If FTC Finds Repetitive Pattern

The Federal Trade Commission wants to clarify through future case law that repeated petitioning of the government could be subject to antitrust enforcement

Related Content

UsernamePublicRestriction

Register

LL009864

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel